GRK3 is essential for metastatic cells and promotes prostate tumor progression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1521-1526

  Li, Wenliang ^a   Ai, Nanping ^a   Wang, Suming ^b,c   Bhattacharya, Nandita ^d   Vrbanac, Vladimir ^e   Collins, Michael ^f   Signoretti, Sabina ^f   Hu, Yanhui ^c   Boyce, Frederick M ^e   Gravdal, Karsten ^a   Halvorsen, Ole J ^g,h   Nalwoga, Hawa ^g,h   Akslen, Lars A ^g,h   Harlow, Ed ^f   Watnick, Randolph S ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF BERGEN   (Norway)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

ADRBK2; Essential kinases; Functional screens; PAI 2; TSP 1

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 3; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOSPONDIN 1;

ANGIOGENESIS; ARTICLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR GROWTH;

ADRBK2; ESSENTIAL KINASES; FUNCTIONAL SCREENS; PAI-2; TSP-1;

CELL PROLIFERATION; DISEASE PROGRESSION; G-PROTEIN-COUPLED RECEPTOR KINASE 3; HUMANS; MALE; NEOPLASM METASTASIS; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROSTATIC NEOPLASMS; THROMBOSPONDIN 1;

EID: 84893413021     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320638111     Document Type: Article

References (36)

1. Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: Markers and models. Nat Rev Cancer 5(8):591-602.
2. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563-572.
3. Steeg PS (2006) Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12(8):895-904.
4. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12(2):89-96.
5. Fidler IJ (2003) The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453-458.
6. Hüsemann Y, et al. (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13(1):58-68.
7. Podsypanina K, et al. (2008) Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321(5897):1841-1844.
8. Weinberg RA (2008) Leaving home early: reexamination of the canonical models of tumor progression. Cancer Cell 14(4):283-284.
9. Baldwin A, et al. (2008) Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci USA 105(43):16478-16483.
10. Bommi-Reddy A, et al. (2008) Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc Natl Acad Sci USA 105(43):16484-16489.
11. Grueneberg DA, et al. (2008) Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci USA 105(43):16472-16477.
12. Grueneberg DA, et al. (2008) Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proc Natl Acad Sci USA 105(43):16490-16495.
13. Pettaway CA, et al. (1996) Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2(9): 1627-1636.
14. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57.
15. HuangW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1-13.
16. Dvorak HF, et al. (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57(6):673-686.
17. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA (2009) Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res 69(11):4708-4715.
18. Alvarez AA, et al. (2001) Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumor angiogenesis, and survival in platinumtreated patients. Gynecol Oncol 82(2):273-278.
19. Campbell SC, Volpert OV, Ivanovich M, Bouck NP (1998) Molecular mediators of angiogenesis in bladder cancer. Cancer Res 58(6):1298-1304.
20. Croucher DR, Saunders DN, Lobov S, RansonM (2008) Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 8(7):535-545.
21. Good DJ, et al. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87(17):6624-6628.
22. Hsu SC, et al. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56(24):5684-5691.
23. Celver J, Sharma M, Kovoor A (2010) RGS9-2 mediates specific inhibition of agonistinduced internalization of D2-dopamine receptors. J Neurochem 114(3):739-749.
24. Morris GE, Nelson CP, Standen NB, Challiss RA, Willets JM (2010) Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2. Cardiovasc Res 85(3):424-433.
25. Straume O, et al. (2002) Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers. Cancer Res 62(23):6808-6811.
26. Penela P, Murga C, Ribas C, Lafarga V, Mayor F, Jr. (2010) The complex G proteincoupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 160(4):821-832.
27. Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17(4):159-165.
28. Ribas C, et al. (2007) The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768(4):913-922.
29. Benovic JL, et al. (1991) Cloning, expression, and chromosomal localization of betaadrenergic receptor kinase 2. A new member of the receptor kinase family. J Biol Chem 266(23):14939-14946.
30. Benovic JL, et al. (1991) cDNA cloning and chromosomal localization of the human beta-adrenergic receptor kinase. FEBS Lett 283(1):122-126.
31. Vinge LE, et al. (2007) Substrate specificities of g protein-coupled receptor kinase-2 and -3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function. Mol Pharmacol 72(3):582-591.
32. Willets JM, Challiss RA, Nahorski SR (2003) Non-visual GRKs: Are we seeing the whole picture? Trends Pharmacol Sci 24(12):626-633.
33. Woerner BM, et al. (2012) Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth. Mol Cancer Res 10(1):156-166.
34. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3(5):565-577.
35. Chin L, et al. (1999) Essential role for oncogenic Ras in tumour maintenance. Nature 400(6743):468-472.
36. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 324(1):1-8.